Prosecution Insights
Last updated: July 17, 2026

Kagan Binder, Pllc

46 pending office actions • 38 clients • 45 examiners • 34 art units • 0 of 46 (0%) have an AI response strategy ready • 51 patents granted in the last 365 days

Quality Metrics (n=24213 apps, methodology: how we score firms)

84.4%
Allowance Rate
n=24213
+0.58σ
Allowance Rate (norm)
n=24213
3.6
OAs to Allowance
n=13194
-0.03σ
OAs to Allow (norm)
n=13194
1092 days
Time to Allowance
n=13194
+9.1pp
Interview Lift
n=24213
29.7%
RCE Rate
n=24213
2.8%
Appeal Rate
n=24213

Rejection Performance (% of received rejections ultimately overcome)

85.7%
§101 Overcome
n=224
84.0%
§102 Overcome
n=1930
78.5%
§103 Overcome
n=7632
87.1%
§112 Overcome
n=1902

Specialization & Scale

A61K, H01L, A61P
Top CPC Subclasses
16%
Top-3 CPC Share
n=24213
10
Practitioners
n=24213
2421.3
Apps / Practitioner
n=24213

Portfolio Summary

46
Total Pending OAs
33
Non-Final OAs
10
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 21 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
1
Due this week
4
Due this month
4
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 21 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 7 days (1)Due ≤ 30 days (4)Due ≤ 60 days (4)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
34
Medium (74%)
9
Easy (20%)
3
Unknown (7%)

Rejection Statute Mix

BucketCases
§103 only33 (72%)
§102 only1 (2%)
§112 only6 (13%)
Double-patenting only3 (7%)
No statute on record3 (7%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

27
Life Sciences
59% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
3
Semiconductors
7% of docket
12
Mechanical / Eng
26% of docket
4
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

460 h
Manual time on pending OAs
92 h
Time saved (low, 20%)
161 h
Time saved (mid, 35%)
4.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
QIAN, CELINE X 2 47.9% +17.0%
GANCI, MATTHEW JOSEPH 1 92.9% -3.4%
RUNYAN, SILVANA C 1 82.3% +17.2%
WEISS, JESSICA 1 81.3% +32.8%
HERNANDEZ, JACKSON J 1 54.3% +36.9%
GARBER, ERIN R 1 82.0% +17.4%
PACKARD, BENJAMIN J 1 66.5% +15.5%
CROCKETT, RYAN M 1 78.9% +5.4%
PAK, YONG D 1 74.6% +14.1%
ROJOHN III, CLAIRE E 1 66.1% +18.3%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19141640 HYDRAULIC ACTUATOR FOR A SPRING PRELOAD ADJUSTMENT SYSTEM FOR A SHOCK ABSORBER GANCI, MATTHEW JOSEPH
19095272 COMPOSITIONS AND METHODS FOR CONTROLLING ASPHALTENE DEPOSITION RUNYAN, SILVANA C
19038240 SURGICAL BONE PLATE SYSTEM WITH FASTENER INDUCED ADAPTIVE FIT WEISS, JESSICA
18961674 OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM GARBER, ERIN R

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18880793 SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT HERNANDEZ, JACKSON J 30d overdue
18709148 SEQUENCE FOR PROTEIN DECAY PAK, YONG D 22d
19095272 COMPOSITIONS AND METHODS FOR CONTROLLING ASPHALTENE DEPOSITION RUNYAN, SILVANA C
19038240 SURGICAL BONE PLATE SYSTEM WITH FASTENER INDUCED ADAPTIVE FIT WEISS, JESSICA
18961674 OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM GARBER, ERIN R
18937498 N-CONTAINING/HUMIC FERTILIZER AND PREPARING METHODS THEREOF PACKARD, BENJAMIN J
18698114 COOLING DEVICE FOR OPTICAL AND/OR ELECTRONIC ELEMENTS ROJOHN III, CLAIRE E
18010407 CELL-MEDIATED SARS-COV-2 VACCINES, AND PREPARATION AND USE THEREOF QIAN, CELINE X

Client Portfolio (38 clients)

Top Art Units

Art UnitApps
37752
28782
16522
37232
16342
37912
16382
16372
36141
36741

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19141640 HYDRAULIC ACTUATOR FOR A SPRING PRELOAD ADJUSTMENT SYSTEM FOR A SHOCK ABSORBER Öhlins Group AB GANCI, MATTHEW JOSEPH 3614 §103 Non-Final OA Pending Jun 20, 2025
19095272 COMPOSITIONS AND METHODS FOR CONTROLLING ASPHALTENE DEPOSITION Championx LLC RUNYAN, SILVANA C 3674 §103 Non-Final OA Pending Mar 31, 2025
19038240 SURGICAL BONE PLATE SYSTEM WITH FASTENER INDUCED ADAPTIVE FIT J.M. Longyear Manufacturing, LLC Dba Able Medical Devices WEISS, JESSICA 3775 §103 Non-Final OA Pending Jan 27, 2025
18880793 SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT Genemind Biosciences Co., Ltd. HERNANDEZ, JACKSON J 1627 §103 Non-Final OA 30d overdue Pending Jan 02, 2025
18961674 OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM Genemind Biosciences Co., Ltd. GARBER, ERIN R 2878 §112 Non-Final OA Pending Nov 27, 2024
18937498 N-CONTAINING/HUMIC FERTILIZER AND PREPARING METHODS THEREOF Huma, Inc. PACKARD, BENJAMIN J §103 Non-Final OA Pending Nov 05, 2024
18818954 IMAGING SYSTEM, SEQUENCING SYSTEM, AND IMAGING METHOD Genemind Biosciences Co., Ltd. CROCKETT, RYAN M §103 Non-Final OA Pending Aug 29, 2024
18709148 SEQUENCE FOR PROTEIN DECAY TriTerp PAK, YONG D 1652 §103 Non-Final OA 22d Pending May 10, 2024
18698114 COOLING DEVICE FOR OPTICAL AND/OR ELECTRONIC ELEMENTS Tomra Sorting GmbH ROJOHN III, CLAIRE E 3763 §103 Non-Final OA Pending Apr 03, 2024
18601319 SCREW CADDY J.M. Longyear Manufacturing, LLC Dba Able Medical Devices SIPP, AMY R. 3775 §103 Non-Final OA Pending Mar 11, 2024
18690542 A PROCEDURAL SEDATION MOUTHPIECE Stairway Medical AB JONES, AISLINN MOIRA §103 Non-Final OA Pending Mar 08, 2024
18686220 BRUSH FOR MAINTENANCE OF INDOOR AND OUTDOOR PADEL TURFS Padmax Group AB HORTON, ANDREW ALAN 3723 §103 Final Rejection 7d Pending Feb 23, 2024
18403262 CRUDE STEROL AS AN ADDITIVE IN ASPHALT BINDER Ergon Asphalt & Emulsions, Inc. MERKLING, SALLY ANNE 1738 DP Non-Final OA Pending Jan 03, 2024
18562690 SNUS CONTAINER SÄVJO PLASTIC AB REYNOLDS, STEVEN ALAN 3735 §103 Non-Final OA Pending Nov 20, 2023
18289283 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. SAMSELL, RILLA MARIE 1624 DP Non-Final OA Pending Nov 02, 2023
18383372 THREE-DIMENSIONAL IMAGING APPARATUS HAVING MULTIPLE PASSIVE NOZZLES FOR MODELING A MULTI MATERIAL THREE-DIMENSIONAL OBJECT Ememo Solutions AB AHMED ALI, MOHAMED K 1743 §103 Non-Final OA Pending Oct 24, 2023
18287437 A METHOD AND DEVICE FOR PRODUCING A PRODUCT COMPRISING A SUBSTRATE WITH AT LEAST ONE PATTERNED LAYER Dp Patterning AB ABRAHAM, JOSE K §112 Non-Final OA Pending Oct 18, 2023
18284706 MICROFLUIDIC CHIP, AND AUTOMATIC SEPARATION AND DETECTION SYSTEM AND METHOD FOR CIRCULATING TUMOR CELL Shenzhen Yhlo Biotech Co., Ltd. CROW, ROBERT THOMAS 1634 §103 Non-Final OA Pending Sep 28, 2023
18281489 METHOD FOR EXTRACTING RESPIRATORY INFORMATION FROM A BIO-IMPEDANCE SIGNAL Onera Technologies B.V. AGAHI, PUYA 3791 §103 Final Rejection 34d Pending Sep 11, 2023
18280908 VACCINE COMPOSITIONS AND METHODS FOR TREATING HSV Redbiotec AG GRIZER, CASSANDRA SENN 1672 DP Non-Final OA Pending Sep 07, 2023
18242912 MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS Genomatica, Inc. RAMIREZ, DELIA M 1652 §102 Final Rejection Pending Sep 06, 2023
18277644 METHOD AND SYSTEM FOR DRYING FOODSTUFF RESIDUAL PRODUCT Elajo Technology Solutions AB YUEN, JESSICA JIPING 3762 §103 Non-Final OA 16d Pending Aug 17, 2023
18277041 PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION Sctbio A.S. JUEDES, AMY E 1644 Other Non-Final OA 30d overdue Pending Aug 11, 2023
18271512 DAMPER ASSEMBLY AND HYDRAULIC SHOCK ABSORBER COMPRISING THE SAME ÖHLINS RACING AB HSIAO, JAMES K 3616 §103 Non-Final OA 46d overdue Pending Jul 10, 2023
18269240 TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODY-DRUG CONJUGATES Sotio Biotech A.S. EDGINGTONGIORDANO, FRANCESCA 1643 Other Non-Final OA 45d overdue Pending Jun 22, 2023
18265896 LENTIVIRUS PACKAGING VECTOR AND PACKAGING METHOD THEREOF Obio Technology (Shanghai) Corp., Ltd. PHILIPOSE, HANNAH SARAH 1631 §103 Non-Final OA Pending Jun 07, 2023
18265857 EXOGENOUS GENE CONTROLLABLE EXPRESSION VIRUS PACKAGING VECTOR AND PACKAGING METHOD Obio Technology (Shanghai) Corp., Ltd. MCCORMICK, CATHERINE LYNN 1638 §103 Final Rejection Pending Jun 07, 2023
18265820 LENTIVIRUS VECTOR WITH CONTROLLABLE EXPRESSION OF GENE OF INTEREST, AND PACKAGING METHOD THEREFOR Obio Technology (Shanghai) Corp., Ltd. JOHNSON, ALLISON MARIE 1638 §103 Non-Final OA 62d Pending Jun 07, 2023
18206206 SAMPLING CATHETER Imperial College Innovations Limited KREMER, MATTHEW 3791 §112 Final Rejection 28d overdue Pending Jun 06, 2023
18203429 SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR Celsprin LLC BASQUILL, SEAN M 1614 §103 Non-Final OA 56d Pending May 30, 2023
18039060 TCR CAPABLE OF RECOGNIZING HPV ANTIGEN Xlifesc, Ltd. PETERS, ALEC JON 1641 §112 Non-Final OA 15d Pending May 26, 2023
18038393 BIOCOMPATIBLE COMPOSITE MEMBRANE, METHOD FOR FABRICATING THE MEMBRANE, BIOREACTOR AND METHOD FOR INVESTIGATING CELLS ATTACHED TO THE BIOCOMPATIBLE COMPOSITE MEMBRANE Julius-Maximilians-Universitaet Wuerzburg PAGUIO FRISING, MICHELLE F 1651 §103 Non-Final OA Pending May 23, 2023
18033524 IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER Cytune Pharma ABBAS, SYED JARAR 1674 Other Non-Final OA 73d overdue Pending Apr 24, 2023
18085952 DEGRADABLE FISHING LINES AND NETS Enviro Cast, LLC XU, JIANGTIAN 1762 §103 Non-Final OA 2d overdue Pending Dec 21, 2022
18010407 CELL-MEDIATED SARS-COV-2 VACCINES, AND PREPARATION AND USE THEREOF Xiushan Yin QIAN, CELINE X 1637 §103 Final Rejection Pending Dec 14, 2022
17922340 SEQUENCING METHOD, ANALYSIS METHOD THEREFOR AND ANALYSIS SYSTEM THEREOF, COMPUTER-READABLE STORAGE MEDIUM, AND ELECTRONIC DEVICE Genemind Biosciences Co., Ltd. PARISI, JESSICA DANIELLE 1684 §103 Non-Final OA 79d Pending Oct 28, 2022
17920606 COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURY Klinikum Der Universität München SWIFT, CANDICE LEE 1657 §103 Final Rejection Pending Oct 21, 2022
17800464 APPLICATION OF VARIATIONS IN NOTCH FAMILY GENES IN PREDICTING SENSITIVITY TO IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH SOLID TUMORS Shanghai Origimed Co., Ltd. SALMON, KATHERINE D 1682 §103 Final Rejection 22d overdue Pending Aug 17, 2022
17786372 QUANTUM COMPUTER AND METHOD FOR CONTROLLING SAME, QUANTUM ENTANGLEMENT DETECTING DEVICE AND QUANTUM ENTANGLEMENT DETECTING METHOD, AND MOLECULE IDENTIFYING DEVICE AND MOLECULE IDENTIFYING METHOD Kyushu University, National University Corporation DOAN, NGHIA M 2851 §103 Non-Final OA 324d overdue Pending Jun 16, 2022
17780421 ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-CoA-DERIVED PRODUCTS Genomatica, Inc. QIAN, CELINE X 1637 §103 Non-Final OA Pending May 26, 2022
17779796 ELECTRON BEAM RADIATION SYSTEM WITH ADVANCED APPLICATOR COUPLING SYSTEM HAVING INTEGRATED DISTANCE DETECTION AND TARGET ILLUMINATION Intraop Medical Corporation CHOI, JAMES J 2878 §103 Final Rejection 20d Pending May 25, 2022
17607007 ZIPPER STRUCTURE THAT HELPS THE FORMATION OF PROTEIN DIMER AND APPLICATION THEREOF Leide Biosciences Co., Ltd. DABKOWSKI, ERINNE R 1654 §112 Final Rejection Pending Oct 27, 2021
17605499 ENGINEERED TRANSAMINASE AND METHODS OF MAKING AND USING Genomatica, Inc. MCKNIGHT, CIARA A 1656 §103 Non-Final OA Pending Oct 21, 2021
17441652 CATSPER-ACTIVITY-TEST FOR DETERMINING MALE INFERTILITY Truion GmbH PENNINGTON, KATIE LEIGH 1634 §112 Non-Final OA 55d Pending Sep 21, 2021
17413468 BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES The Arizona Board Of Regents On Behalf Of The University Of Arizona BENAVIDES, JENNIFER ANN 1675 §103 Non-Final OA 113d overdue Pending Jun 11, 2021
17252565 Dissolvable Wet Wipe Mccormack Innovation Limited HENSON, KATINA N 3723 §103 Non-Final OA 54d Pending Dec 15, 2020

Managing Kagan Binder, Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month